Stockreport

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF momentum, with topline data for all three studies expected in the first quarter of 2027 - Comprehensive data update for VIR-5500, a PSMA-targeting PRO-XTEN ® dual-mask [Read more]